DirectorPrecisionMedicine,Labs&Societies

At AstraZeneca, we are redefining cancer care through precision medicine—ensuring the right patients receive the right therapies at the right time. This role sits at the center of that ambition, crafting how diagnostic ecosystems evolve to support our oncology portfolio today and into the future. We are seeking a senior, enterprise-minded leader to define and drive AstraZeneca’s national laboratory and oncology society engagement strategy, translating scientific innovation into scalable, real-world patient impact. This position reports to the Senior Director, Precision Medicine, and Marketing, and partners broadly across commercial, market access, medical affairs, and alliance organizations. **The Opportunity** As _Director, National Labs & Societies_, you will lead the strategy and execution of AstraZeneca’s engagement with national laboratory networks and key oncology societies, ensuring optimal integration of companion diagnostics into clinical practice. You will operate at the intersection of commercial strategy, market access, and scientific engagement, influencing how biomarker testing is adopted, reimbursed, and operationalized across the U.S. oncology ecosystem. This is a high-impact role with visible enterprise influence, shaping diagnostic strategy across multiple brands and indications while directly contributing to improved patient identification and access. **Key Responsibilities** **Enterprise Leadership in Companion Diagnostics & Lab Strategy** * Define and lead AstraZeneca’s U.S. national lab strategy, including prioritization, partnership models, and long-term ecosystem evolution * Serve as the primary strategic collaborate with leading national lab organizations, driving alignment on testing practices, data exchange, and innovation * Anticipate shifts in diagnostic technologies, reimbursement, and lab consolidation—and proactive position AstraZeneca to lead. **Driving Measurable Patient Impact** * Establish and deliver against clear performance met